** Shares of Australia's Control Bionics rise as much as 3.5% to A$0.090; on track for second straight day of gains, if trend holds
** Medical device maker signs exclusive distribution agreement with UK-based Smart Box Ltd
** Adds agreement to expand sale of co's NeuroNode device into the UK and Ireland
** NeuroNode used for individuals with conditions such as Motor Neurone Disease, cerebral palsy, and other neurological disorders that impair communication and motor function - CBL
** Stock up 95.7% YTD, as of 0220 GMT
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。